ING Groep NV decreased its holdings in Aetna (NYSE:AET) by 93.9% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,905 shares of the company’s stock after selling 29,101 shares during the period. ING Groep NV’s holdings in Aetna were worth $322,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also modified their holdings of AET. Farallon Capital Management LLC bought a new position in Aetna in the fourth quarter worth approximately $940,734,000. Wells Fargo & Company MN increased its position in shares of Aetna by 101.0% during the first quarter. Wells Fargo & Company MN now owns 2,797,748 shares of the company’s stock worth $472,819,000 after purchasing an additional 1,405,859 shares in the last quarter. Deutsche Bank AG increased its position in shares of Aetna by 57.5% during the fourth quarter. Deutsche Bank AG now owns 2,704,723 shares of the company’s stock worth $487,900,000 after purchasing an additional 987,156 shares in the last quarter. Alpine Associates Management Inc. acquired a new position in shares of Aetna during the fourth quarter worth $159,933,000. Finally, Amundi Pioneer Asset Management Inc. increased its position in shares of Aetna by 1,087.9% during the fourth quarter. Amundi Pioneer Asset Management Inc. now owns 926,948 shares of the company’s stock worth $167,213,000 after purchasing an additional 848,913 shares in the last quarter. 84.19% of the stock is owned by institutional investors.
A number of brokerages have recently issued reports on AET. Credit Suisse Group reduced their price target on Aetna from $208.00 to $194.00 and set a “neutral” rating on the stock in a research report on Monday, May 14th. Piper Jaffray Companies reaffirmed a “buy” rating and set a $212.00 price target on shares of Aetna in a research report on Tuesday, January 30th. Cantor Fitzgerald raised Aetna from a “neutral” rating to an “overweight” rating in a research report on Tuesday, May 1st. ValuEngine raised Aetna from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Finally, Zacks Investment Research raised Aetna from a “sell” rating to a “hold” rating in a research report on Thursday, May 3rd. Eight equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $196.36.
Shares of AET opened at $177.72 on Tuesday. The firm has a market cap of $57.83 billion, a PE ratio of 18.02, a P/E/G ratio of 1.49 and a beta of 0.64. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.73 and a current ratio of 0.73. Aetna has a 1-year low of $140.24 and a 1-year high of $194.40.
Aetna (NYSE:AET) last announced its quarterly earnings data on Tuesday, May 1st. The company reported $3.19 earnings per share for the quarter, beating analysts’ consensus estimates of $2.97 by $0.22. The firm had revenue of $15.34 billion for the quarter, compared to analyst estimates of $15.32 billion. Aetna had a net margin of 5.76% and a return on equity of 21.42%. The business’s quarterly revenue was up 1.1% compared to the same quarter last year. During the same period in the previous year, the company earned $2.71 earnings per share. sell-side analysts anticipate that Aetna will post 11.06 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 1st. Stockholders of record on Wednesday, July 25th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date of this dividend is Tuesday, July 24th. Aetna’s dividend payout ratio (DPR) is presently 20.28%.
Aetna Company Profile
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.